Skip to search formSkip to main contentSkip to account menu

EMD 57033

Known as: EMD-57033 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Aims We recently published that the positive inotropic response (PIR) to levosimendan can be fully accounted for by… 
2005
2005
The effects of the cardiotonic potentiator EMD 57033 on different TnC (troponin C) isoforms were investigated. Endogenous… 
2002
2002
External work, efficiency of energy transfer (EET), and mechanical efficiency (defined as the ratio of external work over… 
2000
2000
Ca2+ sensitizers enhance systolic function, but may impair relaxation in vitro; these effects may differ in stunned and normal… 
1997
1997
Because it is not known whether ejection influences the negative effect of the Ca2+-sensitizing drugs on ventricular relaxation… 
1997
1997
Because it is not known whether ejection influences the negative effect of the Ca(2+)-sensitizing drugs on ventricular relaxation… 
1997
1997
1 To date no study has described the cardiovascular effects of increased myofilament Ca2+ responsiveness in awake animals both… 
1996
1996
The results of isolated myocyte and cardiac muscle experiments indicate that inotropic agents that increase responsiveness of… 
1995
1995
1. EMD 57033 produces a positive inotropic effect by increasing the sensitivity of cardiac muscle myofilaments to calcium. Since… 
1993
1993
SummaryEMD 57033 is thought to produce its potentiating effect by increasing the apparent calcium sensitivity of myofibrils. We…